Creative Biosciences (Guangzhou) Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding
- Established
- 2015-01-12
- Employees
- 11
- Market Cap
- -
- Website
- https://www.creativebio.cn
Retrospective Analysis of Colorectal Cancer Screening Results
Completed
- Conditions
- Hyperplastic PolypDigestive System NeoplasmColorectal NeoplasmsNeoplasmsColorectal CancerAdvanced Adenocarcinoma
- Interventions
- Diagnostic Test: SDC2 Gene Methylation Test and Q-FIT TestProcedure: Colonoscopy and/or pathological examination
- First Posted Date
- 2022-05-16
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Creative Biosciences (Guangzhou) Co., Ltd.
- Target Recruit Count
- 822
- Registration Number
- NCT05374369
- Locations
- 🇨🇳
Dongguan Shipai Hospital, Dongguan, Guangdong, China
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Completed
- Conditions
- Lung NeoplasmNon-Small Cell Lung CancerAdenosquamous CarcinomaRespiratory Tract InfectionAcute BronchitisChronic BronchitisChronic Obstructive Pulmonary DiseaseLung CancerSmall Cell Lung CancerSquamous Cell Carcinoma
- Interventions
- Procedure: chest CT or pathological examination
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Creative Biosciences (Guangzhou) Co., Ltd.
- Target Recruit Count
- 1564
- Registration Number
- NCT05337163
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medccal University, Guangzhou, Guangdong, China
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Recruiting
- Conditions
- Urothelial CarcinomaUrinary Bladder StoneBladder CancerUrocystitis
- Interventions
- Diagnostic Test: Urine DNA methylation analysisProcedure: medical imaging and/or cystoscopy and/or pathological examination
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Creative Biosciences (Guangzhou) Co., Ltd.
- Target Recruit Count
- 482
- Registration Number
- NCT05337189
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
Completed
- Conditions
- Hyperplastic PolypColorectal NeoplasmsColorectal CancerDigestive System NeoplasmAdvanced AdenocarcinomaNeoplasms
- Interventions
- Diagnostic Test: Multigene Methylation Detection Kit
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Creative Biosciences (Guangzhou) Co., Ltd.
- Target Recruit Count
- 1273
- Registration Number
- NCT04722055
- Locations
- 🇨🇳
Shandong Cancer Hospital and Institute, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath